7-Aza, 7-thia and 6-deoxo analogs of (225,235')-and (227^,237?)-homobrassinolide were synthesized. They were found to possess weak bioactivity in a lamina-inclination test.
isomer, 3, 6) were slightly less active than 1, while ketone 4 was less than 1%as active as 1.7) 6-Oxa analog 5 showed marginal activity, and lactam 68) and thiolactam 7 were completely inactive. 7) To learn more abqut the structure-activity relationship among brassino-steroids, we synthesized several new analogs (8~12) of homobrassinolide with a modified ring B, and found someof them to be bioactive, whenexamined by the lamina-inclination test.9)
The replacement of the 7-oxygen atom of 2 and 3 with a nitrogen atom was first attempted to provide 8 and 9, because these lactams might show either brassinolide-like growthpromoting activity or anti-brassinolide-like growth-retarding activity. As our previous attempt to synthesize 8 through Beckmannrearrangement of the oxime of 4 was unsuccessful, giving only regioisomer 6, we adopted a new route, as shown in Fig. 2 . The key feature of our new strategy was the employment of a seco-acid, 16a, as an intermediate. Brooks and Ekhato were the first to employ a similar secoacid for the synthesis of a brassinolide-like lactone.10) Starting from stigmasterol, 13a was prepared by the reported method.4'5) Treatment of 13a in acetic acid with bromine in the presence of a small amount of hydrobromic acid11} yielded bromo ketone 14a, for which a AcO''^ACo"h AcO%"^CCbMe AcO'^CO2Me with methanesulfonyl chloride in pyridine furnished 21a. This was heated with sodium thiosulfate in aqueous ethanol, and the resulting S-alkylthiosulfate was treated with iodine to give a disulfide, 22a. Demethylation of 22a was performed by heating it with lithium iodide in 7V, 7V-dimethylformamide14) to yield an acid, 23a. Subsequent alkaline hydrolysis of tetraacetate 23a gave a tetraol, 24a'. Reduction of 24a' with zinc and acetic acid afforded a thiol acid, 25a'. Finally, the desired thiolactone, 10, mp 113~117°C, was obtained through dehydration of 25a' with dicyclohexyl carbodiimide. In the same mannerto as above, 16b was converted to ll, mp 122-130°C. Thirdly, a 6-deoxo analog, 12, was prepared from (22/?,23i?)-homobrassinolide 3, as shown in Fig. 3 . This was performed to determine the influence of the carbonyl oxygen atom at C-6 on the bioactivity of brassino-steroids.
Reduction of 3 with lithium aluminum hydride gave (2R)3S>22S,23S,24S)-2,3,22,23-Tetraacetoxy-24-ethyl-B-homo-7-aza-5<x-cholestan-6-one,
17a. An aqueous solution (9.2ml) of NaIO4 (555mg, 3eq) was added to a solution of 15a (575mg, 0.867mmol) in AcOH (27.5ml). The mixture was stirred for 17hr at room temperature. Then the mixture was extracted with ether (300ml 
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Tetraacetoxy-24-ethyl-B-homo-7-aza-5(x-cholestan-6-one, 17b. In a similar manner to as described for 16a, crude 16b (223mg) was obtained from 15b (251mg). {2R,3S, 7RS)-2,3-Diacetoxy-7-hydroxy-5a-cholestan-6-one, 15c. In a similar manner to as described for 15a, 15c {2R,3S)-2,3-Diacetoxy-B-homo-7-aza-5a-cholestan-6-one, 17c. In a similar manner to as described for 17a, 17c 3H, d, 7=6Hz ethyl-6, 7-seco-7-hydroxy-5cn-cholestan-6-oate, 20a. To a solution of 19a (1.105g, 1.595mmol) in EtOH (llml) was added NaBH4 (60 mg) with ice-cooling and stirring. The mixture was stirred for 1.5 hr with ice-cooling. Then the mixture was neutralized by the addition of acetic acid, and concentrated in vacuo to dryness. The residue was extracted with EtOAc. The EtOAc solution was washed with water three times, dried over Na2SO4and concentrated in ethyl-6, 7-seco-6-nor-5-methoxycarbonyl-5oi-cholestan-7-yl]disulfide, 22a. A mixture of 21a (626mg, 0.810mmol) and Na2S2O3-5H2O (300mg) in EtOH (6ml) and water (3 ml) was heated under reflux for 8 hr. After cooling, the mixture was concentrated in vacuo to dryness. The residue was extracted with EtOAc. The extract was washedtwice with brine, dried over Na2SO4and concentrated in vacuo to give the crude S-alkylthiosulfate Na-salt. The residue and I2 (205mg) were dissolved in aqueous EtOH (50%, 14 ml), and then the mixture was vigorously stirred for 2 hr at roomtemperature. Then the mixture was filtered to remove precipitate, and the filtrate was concentrated in vacuo. The residue was extracted with CHC13.The CHC13 solution was washed with water, dried over Na2SO4and concentrated in vacuo. The precipitate described above and the residue from the CHC13extract were combined, and purified by silica gel column chromatography. Elution with CHCl3-EtOAc (10: 1) gave 22a (480mg, 83% e thyl-6, 7-seco -6-no r-5-carboxy-5a.-cholestan-7-yl]disulfide> 23a. Lil (2.0g, dried in vacuo at 100°C for 24hr) was added to a solution of22a (397mg, 0.280mmol) in DMF(8ml). The mixture was stirred and heated under reflux for 20 hr under argon. After cooling, the mixture was poured into ice-cooled water, and its pH was adjusted to -3 by the addition of 1 m HC1 aq. Then the mixture was filtered. The solid on the filter was washed with water and dissolved in CHC13. The CHC13 solution was dried over Na2SO4 and concentrated in vacuo. The residue was purified by silica gel column chromatography. Elution with CHCl3-EtOAc (4: 1-1 : 1) gave 23a (247mg, 65%). Recrystallization from «-hexane-EtOAc gave an analytical sample, mp Comparison of the^-NMRspectra for 10 and ll shows the possibility that one of the conformational isomers on ring B was isolated in the case of ll. The results of bioassaying of ll in the absence and presence of brassinolide are shown in Table II. (2R,3S,22R,23R,24S)-24-Ethyl-6, 7-seco-5a-cholestane-2,3,6,7,22,23-hexaol, 26. LiAlH4 (22mg) was added to a solution of 3 (58.0mg, 0.117mmol) in THF (12ml) with stirring and ice-cooling. The mixture was stirred for 3 hr at roomtemperature. After addition of a small amount of water, the mixture was stirred for a few minutes. CHC13 and 1 m HC1aq. were added to the mixture with stirring, and then the CHC13layer was separated. The aq. layer was extracted with CHC13. The CHC13layer and the extract
